Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Dose Response in Opioid Abusers
NCT00460239Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by Johns Hopkins University. Started Jan 2007; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00460239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460239.